Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:17 PM
Ignite Modification Date:
2025-12-24 @ 12:17 PM
NCT ID:
NCT03127761
Eligibility Criteria:
Inclusion Criteria:
* Medicare beneficiary
* Stage II or III multiple myeloma and/or primary plasma cell leukemia
* Eligible to receive an allogeneic HCT from any suitable allogeneic donor (as determined by the transplant center) including umbilical cord blood
* Will receive allogeneic HCT at a US transplant center
* Agree to submit comprehensive clinical data on their pre- and post-transplant clinical status and outcomes to the CIBMTR
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT03127761
Study Brief:
Protocol Section:
NCT03127761